Ag Novartis, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 92,522 shares at $23.94 ($2.2M) on 2017-05-31, disclosed to the SEC on 2017-06-02.
Open-market sale of $2.2M RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.94 | 35,539 | $851K | 38.4% |
| 2 | $23.94 | 35,539 | $851K | 38.4% |
| 3 | $23.89 | 10,722 | $256K | 11.6% |
| 4 | $23.89 | 10,722 | $256K | 11.6% |
| Total | $23.93 avg | 92,522 | $2.2M | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |